ADRIAMYCIN AND THE HEART

[1] BALCERZAK SP, 1978, CANCER TREAT REP, V62, P893

[2] BLUM RH, 1975, CANCER CHEMOTH REP 3, V6, P247

[3] DOXORUBICIN CARDIOMYOPATHY - EVALUATION BY PHONOCARDIOGRAPHY, ENDOMYOCARDIAL BIOPSY, AND CARDIAC-CATHETERIZATION [J]. ANNALS OF INTERNAL MEDICINE, 1978, 88 (02) : 168 - 175

[4] GILLADOGA AC, 1976, CANCER, V37, P1070, DOI 10.1002/1097-0142(197602)37:2+<1070::AID-CNCR2820370814>3.0.CO

[5] 2-6

[6] GOSALVEZ M, 1979, CANCER RES, V39, P257

[7] HENDERSON IC, 1978, P AM ASSOC CANC RES, V19, P158

[8] HENDERSON IC, 1978, CANCER TREAT REP, V62, P923

[9] CARDIOTOXICITY OF ADRIAMYCIN AND RELATED ANTHRACYCLINES [J]. CANCER TREATMENT REVIEWS, 1976, 3 (03) : 111 - 120

[10] ASSESSMENT OF CARDIAC-PERFORMANCE WITH QUANTITATIVE RADIONUCLIDE ANGIOCARDIOGRAPHY - SEQUENTIAL LEFT-VENTRICULAR EJECTION FRACTION, NORMALIZED LEFT-VENTRICULAR EJECTION RATE, AND REGIONAL WALL MOTION [J]. CIRCULATION, 1977, 56 (05) : 820 - 829

[1] BALCERZAK SP, 1978, CANCER TREAT REP, V62, P893

[2] BLUM RH, 1975, CANCER CHEMOTH REP 3, V6, P247

[3] DOXORUBICIN CARDIOMYOPATHY - EVALUATION BY PHONOCARDIOGRAPHY, ENDOMYOCARDIAL BIOPSY, AND CARDIAC-CATHETERIZATION [J]. ANNALS OF INTERNAL MEDICINE, 1978, 88 (02) : 168 - 175

[4] GILLADOGA AC, 1976, CANCER, V37, P1070, DOI 10.1002/1097-0142(197602)37:2+<1070::AID-CNCR2820370814>3.0.CO

[5] 2-6

[6] GOSALVEZ M, 1979, CANCER RES, V39, P257

[7] HENDERSON IC, 1978, P AM ASSOC CANC RES, V19, P158

[8] HENDERSON IC, 1978, CANCER TREAT REP, V62, P923

[9] CARDIOTOXICITY OF ADRIAMYCIN AND RELATED ANTHRACYCLINES [J]. CANCER TREATMENT REVIEWS, 1976, 3 (03) : 111 - 120

[10] ASSESSMENT OF CARDIAC-PERFORMANCE WITH QUANTITATIVE RADIONUCLIDE ANGIOCARDIOGRAPHY - SEQUENTIAL LEFT-VENTRICULAR EJECTION FRACTION, NORMALIZED LEFT-VENTRICULAR EJECTION RATE, AND REGIONAL WALL MOTION [J]. CIRCULATION, 1977, 56 (05) : 820 - 829